Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & Administrative
Others
Ratios

Odyssey Health (ODYY) Research & Development (2021)

Odyssey Health (ODYY) has 2 years of Research & Development data on record, last reported at $1.0 million in Q3 2021.

  • For Q3 2021, Research & Development changed N/A year-over-year to $1.0 million; the TTM value through Jul 2021 reached $1.6 million, changed N/A, while the annual FY2024 figure was $55166.0, 67.55% down from the prior year.
  • Research & Development reached $1.0 million in Q3 2021 per ODYY's latest filing, up from $565764.0 in the prior quarter.
  • Across five years, Research & Development topped out at $1.0 million in Q3 2021 and bottomed at $30000.0 in Q2 2017.